Logo image of ELK.OL

ELKEM ASA (ELK.OL) Stock Fundamental Analysis

Europe - OSL:ELK - NO0010816093 - Common Stock

26.8 NOK
+2.26 (+9.21%)
Last: 9/18/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, ELK scores 4 out of 10 in our fundamental rating. ELK was compared to 66 industry peers in the Chemicals industry. Both the profitability and the financial health of ELK get a neutral evaluation. Nothing too spectacular is happening here. ELK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

ELK had negative earnings in the past year.
ELK had a positive operating cash flow in the past year.
In the past 5 years ELK has always been profitable.
ELK had a positive operating cash flow in each of the past 5 years.
ELK.OL Yearly Net Income VS EBIT VS OCF VS FCFELK.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B 8B 10B

1.2 Ratios

ELK has a Return On Assets of -0.92%. This is in the lower half of the industry: ELK underperforms 60.61% of its industry peers.
ELK has a Return On Equity of -1.87%. This is in the lower half of the industry: ELK underperforms 62.12% of its industry peers.
The Return On Invested Capital of ELK (2.72%) is comparable to the rest of the industry.
ELK had an Average Return On Invested Capital over the past 3 years of 8.73%. This is above the industry average of 6.62%.
The 3 year average ROIC (8.73%) for ELK is well above the current ROIC(2.72%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.92%
ROE -1.87%
ROIC 2.72%
ROA(3y)6.39%
ROA(5y)6.2%
ROE(3y)11.85%
ROE(5y)12.17%
ROIC(3y)8.73%
ROIC(5y)8.61%
ELK.OL Yearly ROA, ROE, ROICELK.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

In the last couple of years the Profit Margin of ELK has declined.
ELK has a better Operating Margin (8.03%) than 63.64% of its industry peers.
In the last couple of years the Operating Margin of ELK has grown nicely.
The Gross Margin of ELK (52.20%) is better than 80.30% of its industry peers.
ELK's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.03%
PM (TTM) N/A
GM 52.2%
OM growth 3Y-7.33%
OM growth 5Y22.64%
PM growth 3Y-41.92%
PM growth 5Y-6.54%
GM growth 3Y0.8%
GM growth 5Y2.02%
ELK.OL Yearly Profit, Operating, Gross MarginsELK.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

4

2. Health

2.1 Basic Checks

ELK has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ELK remains at a similar level compared to 1 year ago.
ELK has more shares outstanding than it did 5 years ago.
ELK has a better debt/assets ratio than last year.
ELK.OL Yearly Shares OutstandingELK.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
ELK.OL Yearly Total Debt VS Total AssetsELK.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

ELK has an Altman-Z score of 1.75. This is a bad value and indicates that ELK is not financially healthy and even has some risk of bankruptcy.
ELK has a worse Altman-Z score (1.75) than 65.15% of its industry peers.
ELK has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
ELK's Debt to Equity ratio of 0.48 is in line compared to the rest of the industry. ELK outperforms 46.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z 1.75
ROIC/WACC0.36
WACC7.48%
ELK.OL Yearly LT Debt VS Equity VS FCFELK.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

A Current Ratio of 3.00 indicates that ELK has no problem at all paying its short term obligations.
The Current ratio of ELK (3.00) is better than 86.36% of its industry peers.
A Quick Ratio of 1.56 indicates that ELK should not have too much problems paying its short term obligations.
ELK has a better Quick ratio (1.56) than 74.24% of its industry peers.
Industry RankSector Rank
Current Ratio 3
Quick Ratio 1.56
ELK.OL Yearly Current Assets VS Current LiabilitesELK.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.39% over the past year.
Measured over the past years, ELK shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.90% on average per year.
ELK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -35.34%.
Measured over the past years, ELK shows a decrease in Revenue. The Revenue has been decreasing by -4.35% on average per year.
EPS 1Y (TTM)11.39%
EPS 3Y-53.14%
EPS 5Y-11.9%
EPS Q2Q%-136.3%
Revenue 1Y (TTM)-35.34%
Revenue growth 3Y-18.65%
Revenue growth 5Y-4.35%
Sales Q2Q%-3.33%

3.2 Future

The Earnings Per Share is expected to grow by 40.58% on average over the next years. This is a very strong growth
Based on estimates for the next years, ELK will show a small growth in Revenue. The Revenue will grow by 2.45% on average per year.
EPS Next Y-151.08%
EPS Next 2Y37.54%
EPS Next 3Y40.58%
EPS Next 5YN/A
Revenue Next Year-5.95%
Revenue Next 2Y1.15%
Revenue Next 3Y2.45%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ELK.OL Yearly Revenue VS EstimatesELK.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10B 20B 30B 40B
ELK.OL Yearly EPS VS EstimatesELK.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 10 15

3

4. Valuation

4.1 Price/Earnings Ratio

ELK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 18.16, the valuation of ELK can be described as rather expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as ELK.
When comparing the Price/Forward Earnings ratio of ELK to the average of the S&P500 Index (22.88), we can say ELK is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 18.16
ELK.OL Price Earnings VS Forward Price EarningsELK.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

83.33% of the companies in the same industry are more expensive than ELK, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.91
ELK.OL Per share dataELK.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

ELK has a very decent profitability rating, which may justify a higher PE ratio.
ELK's earnings are expected to grow with 40.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.54%
EPS Next 3Y40.58%

1

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.21%, ELK has a reasonable but not impressive dividend return.
ELK's Dividend Yield is slightly below the industry average, which is at 3.04.
With a Dividend Yield of 1.21, ELK pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.21%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y37.54%
EPS Next 3Y40.58%
ELK.OL Yearly Income VS Free CF VS DividendELK.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B 8B

ELKEM ASA

OSL:ELK (9/18/2025, 7:00:00 PM)

26.8

+2.26 (+9.21%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-11 2025-07-11/bmo
Earnings (Next)10-23 2025-10-23
Inst Owners20.98%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap17.14B
Analysts78
Price Target26.32 (-1.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.21%
Yearly Dividend6.02
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2034.13%
Min EPS beat(2)-2351.11%
Max EPS beat(2)-1717.16%
EPS beat(4)0
Avg EPS beat(4)-1057.71%
Min EPS beat(4)-2351.11%
Max EPS beat(4)-52.09%
EPS beat(8)1
Avg EPS beat(8)-1159.62%
EPS beat(12)3
Avg EPS beat(12)-775.14%
EPS beat(16)7
Avg EPS beat(16)-577.5%
Revenue beat(2)1
Avg Revenue beat(2)-0.25%
Min Revenue beat(2)-5.85%
Max Revenue beat(2)5.35%
Revenue beat(4)2
Avg Revenue beat(4)-2.17%
Min Revenue beat(4)-12.1%
Max Revenue beat(4)5.35%
Revenue beat(8)4
Avg Revenue beat(8)-2.65%
Revenue beat(12)6
Avg Revenue beat(12)-1.83%
Revenue beat(16)8
Avg Revenue beat(16)-0.79%
PT rev (1m)0%
PT rev (3m)9.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-121%
EPS NY rev (1m)-132.4%
EPS NY rev (3m)-132.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.98%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 18.16
P/S 0.83
P/FCF N/A
P/OCF 10.29
P/B 0.72
P/tB 0.73
EV/EBITDA 5.91
EPS(TTM)-0.7
EYN/A
EPS(NY)1.48
Fwd EY5.51%
FCF(TTM)-2
FCFYN/A
OCF(TTM)2.61
OCFY9.72%
SpS32.13
BVpS37.28
TBVpS36.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.92%
ROE -1.87%
ROCE 3.73%
ROIC 2.72%
ROICexc 2.91%
ROICexgc 2.95%
OM 8.03%
PM (TTM) N/A
GM 52.2%
FCFM N/A
ROA(3y)6.39%
ROA(5y)6.2%
ROE(3y)11.85%
ROE(5y)12.17%
ROIC(3y)8.73%
ROIC(5y)8.61%
ROICexc(3y)10.76%
ROICexc(5y)10.71%
ROICexgc(3y)11.49%
ROICexgc(5y)11.66%
ROCE(3y)12.41%
ROCE(5y)12.33%
ROICexcg growth 3Y-39.97%
ROICexcg growth 5Y-3.21%
ROICexc growth 3Y-38.01%
ROICexc growth 5Y-2.06%
OM growth 3Y-7.33%
OM growth 5Y22.64%
PM growth 3Y-41.92%
PM growth 5Y-6.54%
GM growth 3Y0.8%
GM growth 5Y2.02%
F-Score6
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA 2.54
Cap/Depr 104.17%
Cap/Sales 14.33%
Interest Coverage 1.99
Cash Conversion 37.2%
Profit Quality N/A
Current Ratio 3
Quick Ratio 1.56
Altman-Z 1.75
F-Score6
WACC7.48%
ROIC/WACC0.36
Cap/Depr(3y)178.1%
Cap/Depr(5y)168.55%
Cap/Sales(3y)17.35%
Cap/Sales(5y)14.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.39%
EPS 3Y-53.14%
EPS 5Y-11.9%
EPS Q2Q%-136.3%
EPS Next Y-151.08%
EPS Next 2Y37.54%
EPS Next 3Y40.58%
EPS Next 5YN/A
Revenue 1Y (TTM)-35.34%
Revenue growth 3Y-18.65%
Revenue growth 5Y-4.35%
Sales Q2Q%-3.33%
Revenue Next Year-5.95%
Revenue Next 2Y1.15%
Revenue Next 3Y2.45%
Revenue Next 5YN/A
EBIT growth 1Y483.39%
EBIT growth 3Y-24.62%
EBIT growth 5Y17.3%
EBIT Next Year214.92%
EBIT Next 3Y61.29%
EBIT Next 5YN/A
FCF growth 1Y-213.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-72.6%
OCF growth 3Y-25.52%
OCF growth 5Y2%